ArticleGels (Basel, Switzerland)2026

Translating a Preclinical Hydrogel Platform into a Human Therapeutic for Delivering Targeted Low-Dose Anti-CTLA-4.

Airi Harui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.